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Isolated iliac artery aneurysms are relatively
uncommon, with an incidence rate as low as 0.03%
in a large autopsy series.1 In clinical series, these
aneurysms account for 2% to 7% of atherosclerotic
aneurysms of the aortoiliac segment.2-6 These
aneurysms are multiple in as many as 67% of the
patients as reported by Richardson and Greenfield4
and are often asymptomatic. About half of patients
have symptoms that include rupture, embolization,
thrombosis, and pressure symptoms, much like
symptomatic abdominal aortic aneurysms. Difficulty
in the detection of these aneurysms as a result of
their location and the technical difficulties associat-
ed with the repair of these pelvic arterial lesions, par-
ticularly in patients with a history of previous aortic
surgery, make treatment a continuing challenge. The
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mortality rates after rupture and emergent surgery
for the repair of these aneurysms are as high as 33%,4
and the mortality rates after elective repair have been
slightly worse than after abdominal aneurysm repair,
averaging around 10% (range, 0 to 50%) in pub-
lished series.2-6 The treatment results continue to
improve, as reported recently by Krupski et al7 who
experienced no perioperative mortalities in a group
of 19 patients at good risk. Interestingly, these inves-
tigators treated their two patients who were at high
risk with endovascular techniques.7
Iliac artery pseudoaneurysms are caused by pre-
vious surgery, trauma, or other intravascular medical
interventions. Anastomotic pseudoaneurysms are
relatively uncommon, with an observed incidence
rate of 0.2% to 15% in different series.8-10 Other
pseudoaneurysms that are the result of trauma or
medical interventions are even less common.
Untreated pseudoaneurysms are prone to the same
complications as are true aneurysms, with operative
mortality rates of 8% to 19% in elective cases of anas-
tomotic pseudoaneurysm repair.11,12 The associated
mortality rates after emergency surgery are even
higher.11,12 The high morbidity and mortality rates
are caused by technical difficulties associated with
secondary intra-abdominal or retroperitoneal vascu-
lar operations, obliteration of normal tissue planes
by the pseudoaneurysm, and the aging of the gener-
al population. Morever, many of these life-threaten-
ing aneurysms and pseudoaneurysms exist in
patients with multiple comorbid medical conditions
that make standard open surgical repair risky.
Alternative therapies with simple aneurysm liga-
tion, coil embolization, or the placement of porous
intravascular stents have been used in an attempt to
treat these isolated iliac aneurysms.7,13-14 Although
radiographic exclusion has been shown with these
techniques, continued growth and rupture of the
aneurysms have been repeatedly documented.7,15-18
Endovascular grafts, which were initially used for the
treatment of inoperable aortic aneurysms, are the
most recent alternative for the treatment of iliac
aneurysms and other arterial lesions. This form of less
invasive treatment holds the promise of decreased
perioperative morbidity and mortality rates.19-22 This
report describes our 5-year experience with the use of
endovascular grafts for the treatment of 40 isolated
iliac aneurysms and pseudoaneurysms with follow-up
periods as long as 51 months.
PATIENTS AND METHODS
Patients. Thirty-nine patients (36 men, three
women) with a total of 40 isolated iliac aneurysms or
pseudoaneurysms (32 true aneurysms and eight
pseudoaneurysms) underwent treatment at Monte-
fiore Medical Center (n = 30) and Morristown
Memorial Hospital (n = 10) between August 1993
and August 1998. The mean age of the patients was
68 years (range, 56 to 88 years). All the patients had
at least one significant comorbid medical condition
that increased the risk for standard surgical repair as
suggested by the Society for Vascular Surgery/
International Society for Cardiovascular Surgery Ad
Hoc Committee on Reporting Standards.23 These
comorbid conditions included: moderate or severe
coronary artery disease in 63% of the patients, mod-
erate or severe hypertension in 38% of the patients,
moderate or severe chronic obstructive pulmonary
disease in 25% of the patients, severe chronic renal
insufficiency in 10% of the patients, and previous
aortoiliac surgery or major intra-abdominal or
retroperitoneal procedures in 25% of the patients.
The 40 iliac aneurysms and pseudoaneurysms that
were treated included: 28 common iliac aneurysms,
four internal iliac aneurysms, four common iliac
pseudoaneurysms, and four external iliac pseudoa-
neurysms. The aneurysms ranged in diameter from
2.5 to 11 cm (mean, 5.2 cm). No aneurysm showed
evidence of free rupture at the time of the preopera-
tive computed tomographic (CT) scan and arteri-
ogram. The patients were followed from 1 to 51
months, with a mean follow-up period of 18 months.
Only one patient was temporarily lost to follow-up
examination after the first postoperative visit and was
seen, 18 months after the endovascular repair, with a
rupture of the previously treated iliac aneurysm.
Endovascular graft devices. Most isolated iliac
aneurysms and pseudoaneurysms (n = 37) were
excluded with a transluminally placed endovascular
graft (TPEG).19-21 All the TPEGs used in this study
were constructed with 6-mm polytetrafluoroethyl-
ene grafts (W.L. Gore and Associates, Flagstaff, 
Ariz; and Impra, Inc, Tempe, Ariz). Each graft 
was sutured to a Palmaz balloon expandable stent
(Johnson & Johnson Interventional Systems,
Warren, NJ), with 50% to 100% of the stent covered
by the overlying graft. The ends of the graft were
marked with 0.010-in radiopaque gold wire for pre-
cise proximal deployment of the endovascular graft
and exact placement of a second distal stent across
the end of the graft when it ended within the exter-
nal iliac arteries. Alternatively, the distal end of the
graft was cut to the appropriate length and sutured
within the ipsilateral common femoral artery, which
created an endovascular anastomosis. The endovas-
cular graft was coaxially mounted on an appropriate-
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ly sized angioplasty balloon and packaged within an
introducer sheath that ranged from 14F to 20F in
diameter.
Three patients underwent repair of external iliac
artery pseudoaneurysms with the Corvita endolumi-
nal graft (Corvita Corporation, Miami, Fla). This
endovascular graft consists of a tubular self-expanding
multiwire braid made from Phynox (Elgiloy, Corvita
Corporation) wire lined with a porous polycarbonate
urethane (Corethane, Corvita Corporation) elas-
tomer. The corethane structure is made from many
layers of spun fibers bonded to each other to form a
well-controlled, non-woven structure. The corethane
liner is integrally bonded to the braided wire structure
by means of an interpenetrating network of fibers that
traverse the interstices of the braid. The 9F Balt intro-
ducer system (Corvita Corporation) was used for the
deployment of this endovascular graft.
The use of all the endovascular grafts was ap-
proved by the respective institutional review boards.
The TPEGs were used under a physician-sponsored
investigational device exemption, and the Corvita
endoluminal grafts were part of a Food and Drug
Administration–approved multicenter study.
Diagnostic evaluation and hypogastric artery
embolization. All the patients underwent preopera-
tive arteriography and contrast-enhanced CT scan-
ning to define the morphologic characteristics of the
aneurysm to be treated, including precise diameter
and length measurements. The size and anatomic
location of the aneurysm, the length of the aneurysm
neck proximally and distally, and the associated aor-
toiliac anatomy were used to plan the endovascular
repair. Various combinations are possible to exclude
iliac aneurysms with endovascular grafts. These have
been described in detail in our initial publication on
this topic in 1995.19 These include the following
combinations: ilioiliac or iliofemoral endovascular
grafts for iliac aneurysms with a good proximal neck
or hypogastric aneurysms, and aortoiliac or aorto-
femoral endovascular grafts with a contralateral
occluding stent and a femorofemoral bypass graft for
patients without a proximal iliac neck or additional
aortoiliac disease.
Ipsilateral hypogastric artery embolization with
appropriately sized embolization coils (Gianturco
coils or Hilal embolization microcoils, Cook, Inc,
Bloomington, Ind) was performed in patients with a
patent ipsilateral hypogastric artery in whom the
planned endovascular graft was to extend across its
orifice and end in the external iliac or femoral arter-
ies. The coils were placed in the proximal portion of
the hypogastric artery, maintaining communication
between its anterior and posterior divisions. Patients
with hypogastric artery aneurysms underwent distal
coil embolization of the anterior and posterior divi-
sions to prevent retrograde flow into the aneurysm
sac after endovascular graft exclusion of the origin of
the hypogastric artery. The embolizations were per-
formed at the time of preoperative diagnostic arteri-
ography or in the operating room just before
endovascular graft deployment.
Endovascular graft deployment technique. All
the procedures were performed in the operating
room, and the devices were introduced into the arte-
rial system through an open femoral arteriotomy.
The devices, within their introducer sheaths, were
coaxially advanced to the planned deployment site
with fluoroscopic control. After retracting the intro-
ducer sheath, the proximal stent was deployed with
the balloon catheter and the remaining graft was
exposed with retraction of the introducer sheath. The
graft was sequentially dilated to mold it to the arter-
ial surface, unfolding all wrinkles and kinks. If the
planned endpoint for the graft was in the external
iliac artery, a second stent was deployed across the
end of the graft visualized fluoroscopically with 
the gold marker. Otherwise, the graft was brought
out through the femoral arteriotomy, cut to the
proper length, and an endoluminal anastomosis per-
formed.25 With the later technique, the length of the
graft was not an issue and any disease in the external
iliac artery was covered by the endovascular graft.
The Corvita endoluminal graft was only used for
patients with external iliac artery pseudoaneurysms.26
This device is fully supported and can be cut to
length. The diameter of the involved artery proximal-
ly and distally was carefully assessed as was the length
of the lesion. The grafts were oversized by 1 to 2 mm
and cut to the necessary length. The graft was then
backloaded into the sheath (9F for 8-mm, 10-mm,
and 12-mm diameter grafts) and introduced over a
guidewire with fluoroscopic control. The grafts were
deployed by holding them in place with a pusher rod
and retracting the introducer sheath to allow self
expansion of the endovascular graft.
Follow-up evaluations. A completion intraop-
erative arteriogram was performed in every case to
ensure complete aneurysm exclusion. A color flow
duplex scan was performed before discharge with
every patient, and a contrast-enhanced CT scan
was performed within the first postoperative
month. All the patients underwent serial contrast-
enhanced CT scan at 6-month intervals if the pre-
vious study showed no leaks and a stable or shrink-
ing aneurysm. The studies were repeated more fre-
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quently if there was any question of an endoleak,
an enlarging aneurysm, or symptoms referable to
the lesion treated.
Statistics. The cumulative primary patency rates
were calculated with the life-table method. The results
were reported in accordance with the guidelines estab-
lished by the Ad Hoc Committee on Reporting
Standards, Society for Vascular Surgery/International
Society for Cardiovascular Surgery, North American
Chapter.27
RESULTS
All the patients underwent initially successful
endovascular treatment of their isolated iliac
aneurysms and pseudoaneurysms. Before endovas-
cular graft placement, 32 patients underwent ipsilat-
eral hypogastric artery coil embolization to prevent
retrograde flow into the aneurysm sac after endovas-
cular aneurysm exclusion. The four patients who
underwent treatment for internal iliac artery
aneurysms underwent successful embolization of the
distal branches of the aneurysm, and the 28 patients
with common iliac artery aneurysms and pseudoa-
neurysms underwent proximal hypogastric artery
embolization. The remaining eight patients had
chronically occluded ipsilateral internal iliac arteries
(n = 5) or had isolated external iliac artery lesions (n
= 3), and the graft was placed distal to the internal
iliac artery origin.
The configuration of the endovascular graft used
was made on the basis of the unique anatomy of
each patient. Most aneurysms and pseudoaneurysms
(98%) had a good proximal neck within the iliac
arteries or the ipsilateral limb of a prior aortobiiliac
graft, allowing a unilateral in-line exclusion of the
aneurysmal lesions. The distal graft ended within the
external iliac artery if the vessel was straight and
healthy (18 grafts; 46%) or at the common femoral
artery with an endoluminal anastomosis if the exter-
nal iliac artery was diseased (22 grafts; 54%). One
patient required an aortoiliac endovascular recon-
struction with a femorofemoral bypass graft and
contralateral iliac occlusion to exclude a large com-
mon iliac artery anastomotic aneurysm without a
well-defined proximal neck.
All the procedures were performed in an operat-
ing room that was fully outfitted for endovascular
procedures. On the basis of the overall condition of
the patients at the time of the procedure, either gen-
eral (n = 7), epidural (n = 28), or local (n = 5) anes-
thesia was used. The median operating time for
these endovascular procedures was 4.5 hours, which
reflects our continuing learning curve (range, 2.5 to
8.0 hours). The average amount of full strength
contrast used during the procedure was 180 mL,
with a range of 90 to 410 mLs. The fluoroscopy
time ranged from 18 to 62 minutes, with a mean of
32 minutes. All the patients were followed from 1 to
51 months (mean, 18 months). The 4-year cumula-
tive primary patency rate in this group of patients
was 94.5% ± 10%, with a major complication rate of
7.5%, a minor complication rate of 15%, and a peri-
operative mortality rate of 2.5%.
The perioperative major complications (within 30
days) included one episode of distal embolization
that required a distal bypass graft 2 months later, an
episode of colonic ischemia that resolved with antibi-
otic therapy and bowel rest, and an episode of graft
thrombosis 3 weeks after endovascular graft place-
ment that required no further treatment because the
patient remained asymptomatic. The minor perioper-
ative complications included five episodes of kinking
or compression of the endovascular graft that
required additional placement of stents within the
graft and one local groin hematoma that required no
further treatment.
There was only one perioperative death in this
series. A patient scheduled for elective repair of a 9-cm
common iliac aneurysm had a hypotensive episode in
the operating room as the procedure was started. The
patient was immediately resuscitated, and an intraop-
erative arteriogram revealed a retroperitoneal rupture
of the large iliac aneurysm. The endovascular repair
was completed expeditiously, but unfortunately the
patient died of postoperative cardiac complications
despite a successful endovascular repair.
The late complications (after 30 days) included
two endoleaks and one graft thrombosis 2 months
after endovascular graft placement. The latter com-
plication was treated with an aortofemoral bypass
grafting procedure. One small proximal endoleak
was present until the patient’s death 18 months after
graft implantation without enlargement of the
aneurysm. The other endoleak occurred in the only
patient who was temporarily lost to follow-up exam-
ination, and this patient was seen 18 months after
the endovascular reconstruction with a contained,
ruptured aneurysm that was successfully repaired in
standard open surgical fashion. In addition, two
patients underwent major amputations during the
follow-up period. These were the results of infrain-
guinal disease and were unrelated to the endovascu-
lar graft. Both patients had undergone additional
infrainguinal arterial reconstructions, which failed at
8 and 10 months and led to limb loss. The endovas-
cular grafts that served as inflow to the failed infrain-
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guinal reconstructions in these two patients
remained patent without any hemodynamic lesions
until the death of the patients from unrelated med-
ical conditions. To date, all the other aneurysms
have remained stable or have decreased in size on
the basis of comparative measurements from the
preoperative and postoperative contrast-enhanced
CT scan results and no secondary or late endoleaks
have been encountered. In this group of patients at
moderate and high risk, the median postoperative
length of hospital stay was 3.0 ± 1.3 days.
DISCUSSION
Isolated iliac aneurysms and pseudoaneurysms
are often asymptomatic, but their natural history
may be associated with significant morbidity and
mortality. Difficulty in the detection of these lesions,
technical concerns associated with their repair in
patients with difficult anatomy and previous aortoil-
iac surgery, and significant comorbid medical condi-
tions make treatment of these conditions a continu-
ing challenge. Endovascular grafts have been used
for the treatment of iliac aneurysms and pseudoa-
neurysms with early encouraging success.19-22,24-26
Further improvements have been made with better
patient selection, procedural enhancements, and
device developments that could lead to a safer and
more efficacious application of this rapidly evolving
technique.
Our 5-year experience reflects the evolution of
this surgical procedure. The 4-year patency rate of
95% compares favorably with published series of
open surgical treatment of iliac aneurysms.3-6 In
addition, these encouraging midterm results were
associated with low morbidity and mortality rates.
Most postoperative complications were caused by
technical aspects of the procedure that have
improved with our growing experience. The episode
of distal embolization was the result of manipula-
tions within a diseased aorta. As technical expertise
has increased and the profile of the introducer sys-
tem has decreased, intra-arterial manipulations have
decreased and become safer, making this complica-
tion less likely. Five patients required further intra-
graft stents to correct areas of kinking and extrinsic
compression. These were necessary in patients with
tortuous, calcified, or diseased iliac arteries because
our TPEG device is not fully supported. Newer
devices, like the Corvita Endoluminal Graft, the
Wallgraft (Schneider, Inc, Minneapolis, Minn), the
Passager graft (Boston Scientific Vascular, BSC,
Wayne NJ), and the Hemobahn device (W.L. Gore
and Associates), are fully supported and may not
need further intragraft support if their radial
strength is sufficient. On the other hand, the need to
support some of our TPEGs to avoid kinking and
narrowing is a reasonable trade off to maintain the
versatility of our device, which is unequaled by any
commercially made endovascular graft. Our system
has the advantages of being applicable to patients
with any combination of sizes of proximal and distal
necks. In addition, it is useful to treat disease that
extends to the femoral arteries, and there is no need
to know the exact length of graft required because
the graft is trimmed to the proper length and
sutured within the common femoral artery.
Another important complication encountered
was colonic ischemia that resolved with nonopera-
tive therapy. The endovascular treatment of many
iliac aneurysms and pseudoaneurysms requires
occlusion of the ipsilateral hypogastric artery that
could have contributed to bowel viability. However,
this was not the case because the hypogastric
embolizations carried out in this series led only to a
single transient episode of colonic ischemia that may
have been in part the result of intraoperative
hypotension. These results are comparable with
series of standard open surgical repair of aortoiliac
aneurysms. Ipsilateral hypogastric artery occlusion
was most commonly associated with postoperative
buttock claudication. These symptoms occur in 10%
to 30% of cases (nine of 32 patients in this series),
improve over time, and can be limited by proximal
hypogastric artery embolization that preserves the
rich pelvic collateral network.
Only two patients had graft thrombosis develop
in this series. Both the endovascular grafts failed
because of technical issues at the proximal attach-
ment site. Residual, hemodynamically significant nar-
rowing was noted with duplex scanning in one
patient after surgery, and the patient refused any fur-
ther interventions. The graft thrombosed 3 weeks
after its insertion. Because the patient was asympto-
matic, no further therapy was necessary. The other
patient’s graft failed 2 months after endovascular
graft placement. Kinking and narrowing of the graft
at the proximal attachment site was noted at the time
of open aortofemoral bypass grafting. These techni-
cal failures could have been better defined and possi-
bly corrected with improved intraoperative comple-
tion arteriography, intravascular ultrasound evalua-
tion, and pressure measurements. In addition, earlier
interventions in patients with “failing” endovascular
grafts may further improve long-term patency.
The other unique long-term complication associ-
ated with the use of endovascular grafts is the exis-
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tence of endoleaks. The endoleak rate in this series
was only 5%. The occurrence of such endoleaks
underscores the importance of long-term follow-up
examinations with duplex or CT scanning in these
patients. The only patient lost temporarily to follow-
up examination had such an endoleak develop that led
to aneurysm rupture. If a large endoleak had been
noted during the follow-up examination, the patient
could have undergone treatment with another
endovascular graft extending from the aorta or with
an attempt at open repair if medically feasible. Major
endoleaks need to be corrected because they can lead
to aneurysm expansion and possible rupture.28,29 In
retrospect, our two endoleaks were the result of poor
patient selection. The proximal necks in these patients
were not suitable for endovascular graft repair. One
neck was short (5 mm), and the other had a rim of
thrombus at the proximal attachment site. An
endovascular reconstruction from the healthier aorta
would have been a better endovascular option to
avoid the development of these endoleaks.
In conclusion, these results show that endovas-
cular repair of isolated iliac aneurysms and pseudoa-
neurysms is a safe and effective technique with good
midterm results in patients at moderate and high
risk. These grafts are particularly beneficial in
patients with medical, surgical, or anatomic con-
traindications for standard open surgical repair.
Continuing improvements in patient selection, pro-
cedural techniques, and the design of endovascular
grafts and their introducer systems will likely contin-
ue to improve the short-term and long-term results
of this evolving surgical technique.
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DISCUSSION
Dr Frank Pomposelli (Boston, Mass). The rational for
this approach is simple: the use and close evaluation of
new less invasive techniques to limit the morbidity and
mortality associated with conventional surgical procedures
while maintaining similar short-term and long-term suc-
cess rates. The approach we describe has not been proven
to be better than conventional retroperitoneal techniques
but, in selected patients with appropriate anatomy who are
at higher risk for perioperative comlications, may be a
good alternative to standard surgical techniques. The case
I showed, in fact, had a small abdominal aortic aneurysm
in addition to the iliac aneurysm. A bifurcated aortic graft
would have been the best operative alternative for this
patient, but he was not considered to be a good surgical
candiate. The aorta was only 4 cm in diameter, and the 9-
cm iliac aneurysm was the life-threatening condition that
needed to be addressed in this elderly, debilitated patient.
The role of endovascular grafting in the treatment of
arterial aneurysms is evolving. Clearly, it is not a technique
that will be applicable to all patients. At this time, the suc-
cess of an endovascular repair is highly dependent on the
anatomy of the aneurysm being treated. If the anatomy is
favorable, high-risk and low-risk patients may benefit from
this type of reconstruction, but the long-term results are
still unknown.
We need to balance the natural history of the disease
in a given patient and the expected results and associated
complications of the treatment techniques we consider to
decide which is the best procedure for specific patients.
Endovascular grafts are not, at this time, the best option
for the treatment of iliac artery aneurysms in all patients.
Nevertheless, their role in the treatment of selected
patients with good anatomy and significant risks of peri-
operative complications is rapidly increasing on the basis
of the published short-term and mid-term results.
Dr Luis A. Sanchez. Correct. I think that the main issue
you have to decide is what is the risk to the patient, and,
obviously, a patient with that kind of anatomy, like the one
that I discussed, in fact had a 4-cm aorta. The patient was
elderly and was referred to us because of his medical con-
traindications. That was a 9-cm iliac aneurysm. We did not
think the aorta was a problem, when he was 80, 81 years old.
Yes, it could have grown. Yes, a better reconstruction
would have been an aortabiiliac or aortobifemoral. I can-
not disagree with that.
I think it is really going to come down to be a balance
of whether the patient has a relatively simple anatomy,
straightforward anatomy, if you are going to have a good
result with a relatively high medical risk. Because that graft
was perfectly straight, I did not think it was going to have a
significant problem in the long-term period. We only know
about 3 to 4 years of follow-up examination, although we
have years of follow-up examinations with aortobiiliac
grafts. Obviously, those are better long-term reconstruc-
tions. There is no question about that.
But we have to balance some of the risks for these
patients, just as the authors were saying in the previous pre-
sentation. What really becomes an economic and other
problem for these patients is the perioperative complications
that affect the rest of their lives.
So, I think it is going to come down to be a real bal-
ance. This graft may not be the best option, but, for first
generation grafting, I think the results were pretty good.
And I think patient selection is really going to be the most
important part of using this device or any other type of
reconstruction you do.
Dr K. Craig Kent (New York, NY). No, I do not think
so. You have to look at the expected long-term survival of
the patient and the short-term and long-term complica-
tions associated with the planned procedure. The best
long-term reconstruction is an aortobifemoral or aortobi-
iliac bypass if it is safe for the patient. In the case of many
patients, medical or surgical factors that increase the
potential complications of the procedure and decreased its
durability have to be considered in choosing the best
treatment alternative. The total complication rate in this
series was just over 20%, but most of these complications
were corrected intraoperatively or were local wound com-
plications. There were no cardiac, cerebrovascular, pul-
monary, or renal complications that often lead to long-
term cost and disability when they occur after convention-
al therapy. Most major complications and failures in this
series were associated with technical errors or poor patient
selection. If the results continue to improve in the short
and long term, this technique may prove to be cost effec-
tive in the future for at least a selected group of patients.
Dr Sanchez. No, I do not think so. You have to look at
what the long-term life expectancy of that patient is. The
best reconstruction they are going to have is going to be an
aortobifemoral or aortobiiliac reconstruction if it is safe for
that patient. And that is, in fact, what I discussed with them.
I think that would be the best option for them. And then
you have to start taking some of the other factors into
account. The other complication rate in the series, as I said,
was 20%, but if you look at the complications themselves,
there were no myocardial infarctions, there were no strokes,
and no patient went into dialysis. You did not have any of
the major complications that lead to long-term cost and
long-term disability to these patients. A groin hematoma, in
fact, and compression, some complications, but those are
intraoperative or intraprocedural things that can be fixed if
you are careful with the procedures. Obviously, we had a
patient whose aneurysm ruptured, and that was the crucial
part of all these repairs. These patients need to be followed
more closely.
This is a first generation device, and, as I mentioned,
patient selection is really the most important part. That
patient should not have been selected for that particular
reconstruction, if he was considered still to be at high risk.
If he was a good risk, he should have undergone a stan-
dard repair because his neck was not a good one.
Dr Glenn LaMuraglia (Boston, Mass). In fact, the
group included eight patients with pseudoaneurysms, five
of which were anastomotic pseudoaneurysms. The other
three were external iliac artery pseudoaneurysms in
patients who had undergone previous transplant nephrec-
tomies or other arterial procedures.
I agree with you that this technique may be particu-
larly useful for the treatment of patients with anasto-
motic pseudoaneurysms after conventional aortoiliac
reconstructions. In these cases, you have the limb of a
graft in which to secure the endovascular graft proxi-
mally. It is likely to provide a very good proximal seal
and a good long-term result. In addition, these patients
would require aortoiliac reoperations that are associated
with higher morbidity and mortality rates in this aging
patient population.
Dr Sanchez. In fact, those three patients had under-
gone previous transplant nephrectomies and had pseudoa-
neurysms develop at the old buttons. They had undergone
two retroperitoneal procedures, and they had localized
pseudoaneurysms where they had the old closures, where
their kidney had been resected.
None of the those cases were anastomotic pseudo-
aneurysms, but we do have a number of those patients. And
I agree with you, for those patients in particular, it is a good
reconstruction. A lot of these patients have undergone an
aortobiiliac graft, had an anastomotic lesion develop, an
anastomotic pseudoaneurysm. You have a proximal graft to
seat an endovascular graft within, which gives you a very
good seal. And you should not have any long-term prob-
lems. Those reoperative patients, as you were saying, are usu-
ally much older since they had their aneurysm fixed, 5, 10,
15 years before. But none of those patients are included in
this series.
Dr David Brewster (Boston, Mass). Sure. In our experi-
ence, we have observed a 10% to 15% incidence rate of but-
tock claudication. The symptoms resolve in most patients
within a few months but can be quite debilitating in active
patients. This is one of the potential complications that have
to be considered during patient selection. A good-risk, active
patient who would require hypogastric occlusion for the
endovascular treatment of aortoiliac aneurysms will be best
served by a conventional surgical repair.
Buttock claudication is more common than the poten-
tial problem of colonic ischemia. We have only observed
an occasional case of colonic ischemia in patients treated
with endovascular grafts after occlusion of one or both
hypogastric arteries. In many of these cases, there are asso-
ciated factors (like hypotension and diffuse embolization)
that are more likely the cause of the ischemic symptoms.
Dr Sanchez. Sure. In fact that is exactly true. We have, in
our experience, somewhere around 10% to 15% buttock
claudication incidence rate. Most of these cases resolve with-
in a month to 2 months, and their symptoms improve. But
that is where I think patient selection really comes into play.
I do not see doing this kind of a reconstruction on a
young, very active patient. I think those patients should
undergo surgical repair. And that has to be kept in mind.
I think that is more of a problem than the potential
problem of colonic ischemia. If you have a patent hypogas-
tric artery on the other side and collateral from the superi-
or mesenteric artery, I do not think colonic ischemia really
has been a problem, even though it is a real theoretic prob-
lem, but buttock claudication has been.
Thank you.
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